About the Authors

Andrew G. Hughson

Contributed equally to this work with: Andrew G. Hughson, Brent Race

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Brent Race

Contributed equally to this work with: Andrew G. Hughson, Brent Race

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Allison Kraus

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Laura R. Sangaré

Affiliation Department of Epidemiology, University of Washington, Seattle, Washington, United States of America

Lori Robins

Affiliation Department of Physical Sciences, University of Washington, Bothell, Washington, United States of America

Bradley R. Groveman

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Eri Saijo

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Katie Phillips

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Luis Contreras

Affiliation Department of Physical Sciences, University of Washington, Bothell, Washington, United States of America

Virkamal Dhaliwal

Affiliation Department of Physical Sciences, University of Washington, Bothell, Washington, United States of America

Matteo Manca

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Gianluigi Zanusso

Affiliation Department of Neurosciences, Biomedicine and Movement Sciences, Policlinico G.B. Rossi, University of Verona, Verona, Italy

Daniel Terry

Affiliation Briotech Inc., Woodinville, Washington, United States of America

Jeffrey F. Williams

Affiliation Briotech Inc., Woodinville, Washington, United States of America

Byron Caughey

bcaughey@nih.gov

Affiliation Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, NIAID, NIH, Hamilton, Montana, United States of America

Competing Interests

I have read the journal's policy and the authors of this manuscript have the following competing interests: DT is founder and CEO of BrioTech Inc, which sells BrioHOClTM. A gift from BrioTech was used to support the work at UW Bothell lead by LR. JFW is Chief Scientific Officer, corporate executive and shareholder of Briotech Inc.

Author Contributions

Conceptualization: BC DT AGH BR AK LRS BRG ES LR DT JFW MM. Funding acquisition: BC DT LR. Investigation: AGH BR AK BRG ES KP VD MM LC LR DT JFW. Methodology: AGH DT BR AK BRG ES MM BC JFW LRS LR. Project administration: BC JFW LRS LR DT. Resources: DT GZ JFW LRS LR. Supervision: BC DT JFW LR. Visualization: AGH BR AK BRG ES LR. Writing – original draft: BC AGH BR AK BRG ES. Writing – review & editing: BC AGH BR AK AK BRG ES JFW LRS LR GZ.